COST-EFFECTIVENESS ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 HOSPITALIZED ADULTS IN MEXICO

被引：0
|
作者：
Ponce-de-Leon, A. [1 ]
Azamar-Alonso, A. [2 ]
Silva-Sanchez, F. [2 ]
Chirino-Sprung, R. [2 ]
Dominguez-Esquivel, V [3 ]
Rajme-Lopez, S. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Gilead Sci Mexico S RL CV, Mexico City, DF, Mexico
[3] HS Estudios Farmacoeconom, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC41
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
    Whittington, Melanie D.
    Pearson, Steven D.
    Rind, David M.
    Campbell, Jonathan D.
    VALUE IN HEALTH, 2022, 25 (05) : 744 - 750
  • [2] A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
    Rafia, Rachid
    Martyn-St James, Marrissa
    Harnan, Sue
    Metry, Andrew
    Hamilton, Jean
    Wailoo, Allan
    VALUE IN HEALTH, 2022, 25 (05) : 761 - 769
  • [3] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
    Rezapour, Aziz
    Behroozi, Zahra
    Nasirzadeh, Mostafa
    Rezaeian, Mohsen
    Barzegar, Mohammad
    Tashakori-Miyanroudi, Mahsa
    Sayyad, Abdollah
    Souresrafil, Aghdas
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [4] Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
    Aziz Rezapour
    Zahra Behroozi
    Mostafa Nasirzadeh
    Mohsen Rezaeian
    Mohammad Barzegar
    Mahsa Tashakori-Miyanroudi
    Abdollah Sayyad
    Aghdas Souresrafil
    Infectious Diseases of Poverty, 12
  • [5] COST-EFFECTIVENESS ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 HOSPITALIZED ADULTS IN THREE COUNTRIES OF LATAM: ARGENTINA, CHILE, AND COLOMBIA
    Montejano, R.
    Riera, F.
    Falistocco, C.
    Espinoza, L.
    Azamar-Alonso, A.
    VALUE IN HEALTH, 2022, 25 (07) : S415 - S415
  • [6] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 IN GREECE
    Athanasakis, K.
    Nomikos, N.
    Tsoulas, C.
    Zisis, K.
    VALUE IN HEALTH, 2022, 25 (12) : S159 - S159
  • [7] Cost-effectiveness analysis of statins for the treatment of hospitalized COVID-19 patients
    Chow, Ronald
    Simone, Charles B., II
    Prsic, Elizabeth Horn
    Shin, Hyun Joon
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (07) : 2285 - 2290
  • [8] Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
    Chhatwal, Jagpreet
    Basu, Anirban
    VALUE IN HEALTH, 2022, 25 (05) : 697 - 698
  • [9] Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
    Jo, Youngji
    Jamieson, Lise
    Edoka, Ijeoma
    Long, Lawrence
    Silal, Sheetal
    Pulliam, Juliet R. C.
    Moultrie, Harry
    Sanne, Ian
    Meyer-Rath, Gesine
    Nichols, Brooke E.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (03):
  • [10] Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
    Kelton, Kari
    Klein, Tim
    Murphy, Dan
    Belger, Mark
    Hille, Erik
    McCollam, Patrick L.
    Spiro, Theodore
    Burge, Russel
    ADVANCES IN THERAPY, 2022, 39 (01) : 562 - 582
12345